LGND

Ligand Pharmaceuticals Incorporated (LGND)

About Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Details

Daily high
$112.66
Daily low
$110.42
Price at open
$110.81
52 Week High
$129.90
52 Week Low
$67.72
Market cap
2.1B
Dividend yield
0.00%
Volume
77,917
Avg. volume
76,099
P/E ratio
44.87

Ligand Pharmaceuticals Incorporated News

Details

Daily high
$112.66
Daily low
$110.42
Price at open
$110.81
52 Week High
$129.90
52 Week Low
$67.72
Market cap
2.1B
Dividend yield
0.00%
Volume
77,917
Avg. volume
76,099
P/E ratio
44.87